R&D
-
Ginkgo on a buying spree, acquires Zymergen
.
Synthetic biology company Ginkgo Bioworks announced today that it plans to acquire Zymergen in an all-stock transaction valued at $300 million in market capitalisation. Zymergen stockholders will receive a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share,…
-
USDA’s bioproduct pilot program
.
Advanced Happy 4th of July to our US readers! Before I become embroiled in analyzing how the latest Supreme Court ruling (in favour of West Virginia) limiting the EPA’s ability to regulate carbon emissions will affect future policies for developing…
-
Admin, Conference, Feedstock, Government, Investments, Opinion, Presentation, R&D, Regulation, studies and reports, Tecnon OrbiChemBIOECONOMY: Poised At A Historic Crossroads
.
Unfortunately, it is getting harder for me to blog with my workload at Tecnon OrbiChem so I am happy to share this Bioeconomy post that our marketing has put up on the TOC blog site based on my presentation in…
-
PHA and PLA partnerships
.
I’ve been attending the 7th World PLA Congress this week reacquainting myself with the polylactic acid (PLA) and lactic acid/lactide markets. According to the 2021 Nova Institute data, the global market size for PLA last year (in terms of capacity)…
-
butanol, Company initiatives, Environment, Feedstock, Investments, Press Release, Products, R&D, RecycleSolvay launches Renewable Materials and Biotech Growth Platform
.
Solvay recently announced the launch of its new Renewable Materials and Biotechnology platform, dedicated to developing innovative and sustainable solutions for a range of markets, using renewable feedstocks and biotechnology. I’ve covered Solvay once in a while and I also…
-
PHA Sample Shop Now Open
.
The member-driven, non-profit industry organization GO!PHA which focuses on the development and commercialization of polyhdyroxyalkanoate (PHA) resins and materials announced this week that it has partnered with Helian Polymers to provide PHA samples at its PHA Sample Shop for academic,…
-
Synthos to build a commercial bio-butadiene plant
.
It has been a long time coming for the commercialization of bio-based butadiene (at least for this one where you can count the percentage renewable content unlike some of the mass balance approaches). I have been monitoring this space for…